Screener
Indivior Pharmaceuticals, Inc. INDV Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
FAQ
- What is Indivior Pharmaceuticals, Inc.'s net income?
- Indivior Pharmaceuticals, Inc. (INDV) reported net income of $89M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s net income changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s net income increased by 89.4% year-over-year, from $47M to $89M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s net income?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc.'s net income has grown at a 70.7% compound annual growth rate (CAGR), from -$42M to $209M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Indivior Pharmaceuticals, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude